Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
INZY

INZY - Inozyme Pharma, Inc. Stock Price, Fair Value and News

$4.00 
Market Closed

Price Targets

INZY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INZY Price Action

Last 7 days

0.3%

Last 30 days

0.8%

Last 90 days

359.8%

Trailing 12 Months

-10.3%

INZY RSI Chart

INZY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INZY Valuation

Market Cap

258.2M

Price/Earnings (Trailing)

-2.42

Price/Free Cashflow

-2.67

INZY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

INZY Fundamentals

INZY Earnings

INZY Profitability

Free Cashflow Yield

-37.39%

INZY Investor Care

About Inozyme Pharma, Inc.

INZY
Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein, which is in Phase 1/2 clinical trials for the treatment of ENPP1 and ABCC6 deficiency, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEinozyme.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES56

Inozyme Pharma, Inc. Frequently Asked Questions

INZY is the stock ticker symbol of Inozyme Pharma, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jul 02 2025, market cap of Inozyme Pharma, Inc. is 258.25 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.